Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia

Clinical Infectious Diseases

Volumn 30, Issue 3, 2000, Pages 466-472

  Garbutt, Jane M ^a   Ventrapragada, Madhuri ^a   Littenberg, Benjamin ^a   Mundy, Linda M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; ENTEROCOCCUS FAECIUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; COHORT STUDIES; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0034035393     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313694     Document Type: Article

References (37)

1. 1. Montecalvo MA, Shay DK, Patel P, et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996; 156:1458-62.
2. 2. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993; 42:597-9.
3. 3. Landry SL. Hospital stay and mortality attributable to nosocomial enterococcal bacteremia. Am J Infect Control 1989; 17:323-9.
4. 4. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31:1280-5.
5. 5. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996; 22:663-70.
6. 6. Barrall DT, Kenney PR, Slotman GJ, Burchard KW. Enterococcal bacteremia in surgical patients. Arch Surg 1985; 120:57-63.
7. 7. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996; 23: 1234-9.
8. 8. Stosor V, Peterson LR, Postelnick M, Noskin GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998; 158:522-7.
9. 9. Morris JG, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann Intern Med 1995; 123: 250-9.
10. 10. Papanicolaou GA, Meyers BR, Meyers J, et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996; 23:760-6.
11. 11. Beezhold DW, Slaughter S, Hayden MK, et al. Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis 1997; 24:704-6.
12. 12. Hoge CW, Adams J, Buchanan B, Sears SD. Enterococcal bacteremia: to treat or not to treat, a reappraisal. Rev Infect Dis 1991; 13:600-5.
13. 13. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1995; 20: 296-301.
14. 14. Traynor P, Sahm D, Mundy LM. Mortality risk from enterococcal bacteremia related to species rather than vancomycin resistance. Infect Control Hosp Epidemiol 1997; 18:32-7.
15. 15. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20:1126-33.
16. 16. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in adult oncology unit. Antimicrob Agents Chemother 1994; 38:1363-7.
17. 17. Stroud L, Edwards J, Danzig L, Culver D, Gaynes R. Risk factors for mortality associated with enterococcal bloodstream infections. Infect Control Hosp Epidemiol 1996; 17:576-80.
18. 18. Lucas GM, Lechtzin N, Puryear W, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 1998; 26: 1127-33.
19. 19. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995; 172:993-1000.
20. 20. Wells CL, Juni BA, Cameron SB, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995; 21:45-50.
21. 21. Wenzel RP. Perspective: attributable mortality - the promise of better antimicrobial therapy. J Infect Dis 1998; 178:917-9.
22. 22. Mundy LM, Traynor P, Sahm D. Implementation of routine enteric screen for vancomycin-resistant Enterococcus faecium in stool Clostridium difficile specimens [abstract]. Clin Infect Dis 1997; 25:418.
23. 23. Garrison T, Traynor P, Windus D, Lu S, Bulliner C, Mundy L. Independent risks for vancomycin-resistant Enterococcus faecium in hemodialysis patients [abstract]. Infect Control Hosp Epidemiol 1998; 19:683.
24. 24. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40.
25. 25. Kollef M. Ventilator-associated pneumonia: a multivariate analysis. JAMA 1993; 270:1965-70.
26. 26. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40:373-83.
27. 27. Knaus W, Draper EA, Wagner DP, Zimmerman JE. Apache II: a severity of disease classification system. Crit Care Med 1985; 13:818-29.
28. 28. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115:585-90.
29. 29. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
30. 30. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial disk susceptibility tests. 5th ed. Publication M2-A5. Villanova, PA: NCCLS, 1993.
31. 31. Sahm DF, Free L, Smith C, Eveland M, Mundy LM. Rapid characterization schemes for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol 1997; 35:2026-30.
32. 32. Rothman KJ, Greenlander S. Modern epidemiology. 2d ed. Philadelphia: Lippincott-Raven, 1998.
33. 33. Feinstein AR. Multivariable analysis: an introduction. New Haven, CT: Yale University Press, 1996.
34. 34. Pittet D, Tarara D, Wenzel P. Nosocomial bloodstream infection in critically ill patients. JAMA 1994; 271:1598-601.
35. 35. Lai KK. Treatment of vancomycin-resistant Enterococcus faecium infections. Arch Intern Med 1996; 156:2579-84.
36. 36. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991; 100: 164-7.
37. 37. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998; 158:182-9.